These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11694836)

  • 1. Cost-effectiveness of syringe exchange as an HIV prevention strategy.
    Laufer FN
    J Acquir Immune Defic Syndr; 2001 Nov; 28(3):273-8. PubMed ID: 11694836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment.
    Nguyen TQ; Weir BW; Des Jarlais DC; Pinkerton SD; Holtgrave DR
    AIDS Behav; 2014 Nov; 18(11):2144-55. PubMed ID: 24824043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
    Lurie P; Gorsky R; Jones TS; Shomphe L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
    AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is your syringe services program cost-saving to society? A methodological case study.
    Des Jarlais DC; Feelemyer J; McKnight C; Knudtson K; Glick SN
    Harm Reduct J; 2021 Dec; 18(1):126. PubMed ID: 34876135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of Streetworks' needle exchange program of Edmonton.
    Jacobs P; Calder P; Taylor M; Houston S; Saunders LD; Albert T
    Can J Public Health; 1999; 90(3):168-71. PubMed ID: 10401166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Needle and syringe programs in Yunnan, China yield health and financial return.
    Zhang L; Yap L; Xun Z; Wu Z; Wilson DP
    BMC Public Health; 2011 Apr; 11():250. PubMed ID: 21507267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Vancouver Canada's supervised injection facility cost-saving?
    Pinkerton SD
    Addiction; 2010 Aug; 105(8):1429-36. PubMed ID: 20653622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study.
    Uyei J; Fiellin DA; Buchelli M; Rodriguez-Santana R; Braithwaite RS
    Lancet Public Health; 2017 Mar; 2(3):e133-e140. PubMed ID: 29253386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Needle exchange programs: an economic evaluation of a local experience.
    Gold M; Gafni A; Nelligan P; Millson P
    CMAJ; 1997 Aug; 157(3):255-62. PubMed ID: 9269195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Needle exchange programs are a cost-effective preventative measure against HIV in Iceland].
    Eythórsson ES; Ásgeirsdóttir TL; Gottfređsson M
    Laeknabladid; 2014 Jul; 100(7-8):379-83. PubMed ID: 25125435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Economic evaluation of needle and syringe exchange in two provinces of Southwest China].
    Xue H; Hu Y; Sun J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):291-5. PubMed ID: 24969453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.
    Holtgrave DR; Pinkerton SD; Jones TS; Lurie P; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S133-8. PubMed ID: 9663636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A benefit-cost analysis of syringe exchange programs.
    Reid RJ
    J Health Soc Policy; 2000; 11(4):41-57. PubMed ID: 10620865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public funding of US syringe exchange programs.
    Des Jarlais DC; McKnight C; Milliken J
    J Urban Health; 2004 Mar; 81(1):118-21. PubMed ID: 15047790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program.
    Perlman DC; Gourevitch MN; Trinh C; Salomon N; Horn L; Des Jarlais DC
    J Urban Health; 2001 Sep; 78(3):550-67. PubMed ID: 11564856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of SEPs.
    Makulowich GS
    AIDS Patient Care STDS; 1998 Feb; 12(2):151-2. PubMed ID: 11361923
    [No Abstract]   [Full Text] [Related]  

  • 20. Syringe exchange programs --- United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(45):1488-91. PubMed ID: 21085091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.